Addex Therapeutics Ltd. (ADXN) Total Liabilities (2022 - 2024)

Addex Therapeutics' Total Liabilities history spans 3 years, with the latest figure at $1.1 million for Q4 2024.

  • For Q4 2024, Total Liabilities fell 71.01% year-over-year to $1.1 million; the TTM value through Dec 2024 reached $1.1 million, down 71.01%, while the annual FY2024 figure was $1.1 million, 70.77% down from the prior year.
  • Total Liabilities for Q4 2024 was $1.1 million at Addex Therapeutics, down from $3.9 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $3.9 million in Q4 2023 and bottomed at $1.1 million in Q4 2024.
  • The 3-year median for Total Liabilities is $3.5 million (2022), against an average of $2.9 million.
  • The largest annual shift saw Total Liabilities grew 12.71% in 2023 before it plummeted 71.01% in 2024.
  • A 3-year view of Total Liabilities shows it stood at $3.5 million in 2022, then grew by 12.71% to $3.9 million in 2023, then tumbled by 71.01% to $1.1 million in 2024.
  • Per Business Quant, the three most recent readings for ADXN's Total Liabilities are $1.1 million (Q4 2024), $3.9 million (Q4 2023), and $3.5 million (Q4 2022).